UNSPSC 51373439: Codeine/guaifenesin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373439 Codeine/guaifenesin is a Commodity code for pharmaceutical products. State and local governments use this code to procure specific branded and generic medications, though recent activity shows a mismatch between the code's nominal scope and actual purchasing: the two most recent opportunities tagged to this code involve naloxone/drug deactivation systems and multi-source generic pharmaceuticals through cooperative purchasing, neither of which directly address codeine/guaifenesin formulations. Issuing bodies range from county health departments to state cooperative purchasing alliances. Seminole County, Florida posted an IFB for naloxone and drug deactivation systems in June 2026, while the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products across participating state and local facilities. The MMCAP procurement reflects the scale and complexity typical of cooperative purchasing vehicles: vendors must supply through authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co.), certify cGMP and Drug Supply Chain Security Act compliance, and maintain specific insurance thresholds, with pricing weighted at 75 percent of evaluation criteria.

Geographic spread includes Florida and Minnesota as primary recent activity, with MMCAP's agreement extending to Oregon. The Seminole County solicitation (IFB60459723LAS) closed July 26, 2023, requesting 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The MMCAP RFP (S1070000015802) had proposals due March 26, 2026, with product availability required by May 15, 2026 and contract effectiveness on July 1, 2026; vendors must submit detailed National Drug Code, SKU, UPC, and manufacturing-location data through CSV-formatted spreadsheets. Neither opportunity discloses explicit set-aside designations. The code shows limited recent activity directly aligned with its stated scope; business developers should verify code assignments against actual product requirements when pursuing pharmaceutical procurement through state and local channels.